# Papers and grey literature

## Papers

Reports from researchers. May or may not have been peer-reviewed yet since this is "moving fast".

### European countries

- [Flaxman2020](https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-Europe-estimates-and-NPI-impact-30-03-2020.pdf?fbclid=IwAR2CpRB6iog24OJIc6TddsHyCLOzdsW4ZlYVcT_oBXdZGvggn6LwYVeNNOw) et al, "Estimating the number of infections and the impact of non- pharmaceutical interventions on COVID-19 in 11 European countries", March 30th 2020. ([local PDF](localpdfs/flaxman2020.pdf))

### UK

- [Ferguson2020](https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf) et al, "Impact of non-pharmaceutical interventions (NPIs) to reduce COVID- 19 mortality and healthcare demand", March 16th 2020. ([local PDF](localpdfs/ferguson2020.pdf))
- [Zhigljavsky20200409](https://arxiv.org/abs/2004.01991) et al, "Generic probabilistic modelling and non-homogeneity issues for the UK epidemic of COVID-19". Has Julia code for running their model. ([local PDF](localpdfs/Zhigljavsky_20200409_generic_probabilistic_COVID19_model_UK.pdf))

### Australia

- [Moss20200407]() et al, "Modelling the impact of COVID-19 in Australia to inform transmission reducing measures and health system preparedness". ([local PDF](MossEtAl_Australian_COVID19_modeling_20200407_with_appendix.pdf))

### USA

- [IHME2020](https://www.medrxiv.org/content/10.1101/2020.03.27.20043752v1), "Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in the next 4 months" ([local PDF](IHME_20200327_covid19_forecasts_US_state_by_state.pdf))

### 'Grey' literature (blog posts and other, non-peer reviewed information)
